Results 11 to 20 of about 5,276 (141)

Estudo comparativo entre as metodologias preconizadas pelo CLSI e pelo EUCAST para avaliação da atividade antifúngica Comparative study of the recommended methodologies by CLSI and EUCAST for activity evaluation antifungal

Química Nova, 2009
The international organizations CLSI and EUCAST developed reference methodologies for activity evaluation antifungal. The aim of this work was to compare the recommended methodologies by the CLSI and EUCAST in the antifungal activity evaluation of crude ...
Marcos Aurélio Stoppa, Luciana Assirati Casemiro, Adriana Helena Chicharo Vinholis, Wilson Roberto Cunha, Márcio Luis Andrade e Silva, Carlos Henrique Gomes Martins, Niege Araçari Jacometti Cardoso Furtado   +6 more
doaj   +2 more sources

Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections? [PDF]

BMC Infectious Diseases, 2012
Background In several European Countries, by the end of 2012, CLSI guidelines will be replaced by EUCAST. We compared antimicrobial susceptibility results of a large number of respiratory pathogens using both EUCAST and previously adopted CLSI criteria ...
Marchese Anna, Esposito Susanna, Barbieri Ramona, Bassetti Matteo, Debbia Eugenio   +4 more
doaj   +3 more sources

bloodstream isolates applying EUCAST over CLSI breakpoints

, 2023
BackgroundCefiderocol is generally active against carbapenem-resistant Klebsiella spp. (CRK) with higher MICs against metallo-beta-lactamase producers. There is a variation in cefiderocol interpretive criteria determined by EUCAST and CLSI. Our objective
Michelle J. Bauer, Özlem Azap, Menekşe, Şirin, Akalin, Halis, Önder Ergönül, Şimsek, Funda, Mehtap Aydın, Bauer, Michelle J. J., David L. Paterson, Keşke, Siran, Akova, Murat, Can, Füsun, Çınar, Güle, Brian Forde, Hamiyet Demirkaya, Aslan, Abdullah Tarik, Gülşen Hazırolan, Murat Akova, Balkan, Ilker Inanç, Doğan, Özlem, Gönen, Mehmet, Mahir Kapmaz, Yağcı, Serap, İşler, Burcu, Abdullah Tarık Aslan, Bauer, Michelle J., Serap Yağcı, Çiğdem Arabacı, Kapmaz, Mahir, Saltoğlu, Neşe, Füsun Can, Alpay Azap, Azap, Ozlem, Demir, Safiye Koçulu, Arabacı, Ciğdem, Azap, Alpay, Elif Tükenmez Tigen, İlker İnanç Balkan, Harris, Patrick N. A., Funda Şimşek, Veli Oğuzalp Bakır, Berna Özer, Paterson, David L. L., ÇINAR, GÜLE, Aydın, Mehtap, Tigen, Elif Tükenmez, Bakir, Veli Oguzalp, Özer, Berna, Forde, Brian, Demirkaya, Hamiyet, Ergönül, Önder, Şirin Menekşe, Şiran Keske, Paterson, David L., Bakır, Veli Oğuzalp, Doğan,Özlem, Necla Tülek, Burcu Isler, Cansel Vatansever, Patrick N. A. Harris, Güle Çınar, Vatansever, Cansel, Tülek, Necla, Halis Akalin, Özlem Doğan, Safiye Koçulu Demir, Neşe Saltoğlu, Caitlin Falconer, Mehmet Gönen, Falconer, Caitlin, Hazırolan, Gülşen   +70 more
core   +2 more sources

PERFORMANCE OF EUCAST RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTING (RAST) FOR SCREENING EXTENDED-SPECTRUM Β-LACTAMASE (ESBL), CARBAPENEMASES IN ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE USING POSITIVE BLOOD CULTURE BROTHS

International Journal of Infectious Diseases, 2023
Intro: Rapid reporting of Antimicrobial susceptibility testing (AST) of blood culture (BC) isolates is critical to optimize therapy. The standard turnaround time (TAT) for identification and AST using conventional disc diffusion (DD) is 48-96 hours after
A. Bhatnagar, R. Gaind
doaj   +1 more source

Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

, 2022
The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is an international susceptibility testing committee, organized by the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) and functioning as the breakpoint ...
Cantón, Rafael, Canton, R, Turnidge, J, Giske, Christian G., Kahlmeter, G, Turnidge, John, Kahlmeter, Gunnar, Giske, CG   +7 more
core   +1 more source

EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures : validation in 55 European laboratories [PDF]

, 2020
Objectives: When bloodstream infections are caused by resistant bacteria, rapid antimicrobial susceptibility testing (RAST) is important for adjustment of therapy.
Åkerlund, Anna, Pätäri, Anu, Grönroos, Juha M., RAST Study Group, Manninen, Raija   +4 more
core   +1 more source

Comparison of Four Methods for the in vitro Susceptibility Testing of Dermatophytes

Frontiers in Microbiology, 2020
ObjectivesInfections caused by dermatophytes affect a high percentage of the population. Antifungal susceptibility testing (AST) can offer useful information about the susceptibility profiles of the pathogens as well as the concomitant documentation of ...
Anthi-Marina Markantonatou, Konstantinos Samaras, Evaggelia Zachrou, Timoleon-Achilleas Vyzantiadis   +3 more
doaj   +1 more source

AMRexpert – online platform for interpretation, verification and validation of antimicrobial susceptibility testing [PDF]

Клиническая микробиология и антимикробная химиотерапия, 2023
Objective. To review the key principles and functionality of AMRexpert online platform. Materials and Methods. The information part of the platform is comprised of rules based on the EUCAST recommendations and various standards for interpreting the ...
Vinogradova A.G., Kuzmenkov A.Yu., Trushin I.V., Edelstein M.V., Sukhorukova M.V., Starostenkov A.A.   +5 more
doaj   +1 more source

Antibiotic Susceptibility Pattern and Bacterial Spectrum Among Patients with External Eye Infections at Menelik II Referral Hospital in Addis Ababa, Ethiopia [Response to Letter]

Infection and Drug Resistance, 2022
Asmamaw Nitsuh Woreta,1,2 Habtamu Biazin Kebede,1 Yonas Tilahun,3 Solomon Gebreselassie Teklegiorgis,1 Woldaregay Erku Abegaz1 1Department of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa ...
Woreta AN, Kebede HB, Tilahun Y, Teklegiorgis SG, Abegaz WE   +4 more
doaj  

Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018–2019)

Journal of Global Antimicrobial Resistance, 2021
: Objectives: : Manogepix, the active moiety of the prodrug fosmanogepix, is a novel antifungal with activity against major fungal pathogens including Candida (except Candida krusei), Aspergillus and difficult-to-treat/rare moulds.
Michael A. Pfaller, Michael D. Huband, Robert K. Flamm, Paul A. Bien, Mariana Castanheira   +4 more
doaj   +1 more source